Frank T. Peters

Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry

Markus R. Meyer, J. Wilhelm, Frank T. Peters et al. · Analytical and Bioanalytical Chemistry · 2010 · 269 citations

Gas Chromatography–mass Spectrometry, Psychoactive Drug, Medicine +8

A microfluidically perfused three dimensional human liver model

Knut Rennert, Sandra Steinborn, Marko Gröger et al. · Biomaterials · 2015 · 238 citations

Engineering, Hepatology, Liver Physiology +7

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)

Hans H. Maurer, Joerg Bickeboeller-Friedrich, Frank T. Peters · Toxicology Letters · 2000 · 206 citations

Psychoactive Drug, Drug Design, Medicine +4

Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

Frank T. Peters, Simone Schaëfer, Roland F. Staack et al. · Journal of Mass Spectrometry · 2003 · 171 citations

Pharmacotherapy, Drug Class, Human Blood Plasma +23

Automated Mass Spectral Deconvolution and Identification System for GC-MS Screening for Drugs, Poisons, and Metabolites in Urine

Markus R. Meyer, Frank T. Peters, Hans H. Maurer · Clinical Chemistry · 2010 · 146 citations · Full text